{"id":389620,"date":"2026-04-21T00:52:09","date_gmt":"2026-04-21T00:52:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/389620\/"},"modified":"2026-04-21T00:52:09","modified_gmt":"2026-04-21T00:52:09","slug":"2-asx-healthcare-shares-i-think-can-beat-the-market","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/389620\/","title":{"rendered":"2 ASX healthcare shares I think can beat the market"},"content":{"rendered":"\n

Healthcare<\/a> is one area of the market I think could be a great place to focus when investing for the long term.<\/p>\n

The combination of ageing populations, rising healthcare spending, and ongoing innovation creates a supportive backdrop that can play out over many years.\u00a0<\/p>\n

With that in mind, here are two ASX healthcare shares that stand out to me right now after falling heavily from their highs.<\/p>\n

\"Two<\/p>\n

Image source: Getty Images<\/p>\n

CSL has been through a difficult period, and that has shown up clearly in the biotech<\/a> giant’s share price.<\/p>\n

Although this has been disappointing, I think it is worth sticking with the ASX healthcare share.<\/p>\n

Its CSL Behring division remains a global leader in plasma therapies, with demand supported by chronic and rare diseases that require ongoing treatment. That creates a recurring revenue<\/a> base that can grow over time as patient numbers increase.<\/p>\n

There is also a pipeline of products and innovation that can support future growth, alongside the company’s vaccine and specialty pharmaceuticals divisions.<\/p>\n

The recent CSL share price weakness has brought valuation multiples back toward levels that look cheap compared to its history. When combined with its positive long-term growth profile, I think that creates a more favourable risk-reward setup.<\/p>\n

Over a 5 to 10 year period, I think CSL has the potential to rebuild momentum as execution improves and its growth drivers continue to play out. This could make it a great buy and hold option.<\/p>\n

ResMed operates in an area that continues to expand globally.<\/p>\n

Sleep apnoea remains significantly underdiagnosed, with management estimating that there are over 1 billion sufferers across the world.<\/p>\n

But with awareness growing thanks to education and technology, demand for ResMed’s devices and software solutions has been increasing and looks set to continue increasing over the next decade.<\/p>\n

ResMed isn’t just selling masks. What stands out to me in is how the company is building an ecosystem.<\/p>\n

It combines its hardware with cloud-based software and data insights, which allows it to support patients and healthcare providers across the full treatment journey. That creates a more connected model and strengthens its competitive position.<\/p>\n

So, with the ResMed share price well below previous highs, I think the setup looks more compelling from a long-term perspective. This is especially with the combination of structural demand and a strong market position giving it a clear pathway to continue growing.<\/p>\n

Foolish takeaway <\/p>\n

Looking ahead, I see both of these ASX healthcare shares benefiting from long-term demand and continued innovation.<\/p>\n

Their recent share price declines may be disappointing for shareholders, but I think they have created an entry point that looks appealing for buy and hold investors.<\/p>\n

Over a five to 10 year timeframe, I think CSL and ResMed shares have the quality and positioning to deliver strong returns and outperform the market.<\/p>\n","protected":false},"excerpt":{"rendered":"Healthcare is one area of the market I think could be a great place to focus when investing…\n","protected":false},"author":2,"featured_media":333963,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[134,527,111,139,69],"class_list":["post-389620","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/389620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=389620"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/389620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/333963"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=389620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=389620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=389620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}